Centre Publications

2015

Please click here for publications from the current year

Please click here for publications from other years

Author(s) Title Year Citation
Sullivan SG, Chow MK, Barr IG and Kelso A Influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza annual report, 2014 2015 Commun Dis Intell Q Rep 39(4): E602-611. 
PubMed link
Laurie KL, Guarnaccia TA, Carolan LA, Yan AW, Aban M, Petrie S, Cao P, Heffernan JM, McVernon J, Mosse J, Kelso A, McCaw JM and Barr IG Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model 2015 J Infect Dis 212(11): 1701-1710. 
PubMed link
DOI:10.1093/infdis/jiv260
Foo SS, Reading PC, Jaillon S, Mantovani A and Mahalingam S Pentraxins and collectins: friend or foe during pathogen invasion? 2015 Trends Microbiol 23(12): 799-811. 
PubMed link
DOI:10.1016/j.tim.2015.09.006
Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG and Reading PC Infection of mouse macrophages by seasonal influenza viruses can be restricted at the level of virus entry and at a late stage in the virus life cycle 2015 J Virol 89(24): 12319-12329. 
PubMed link
DOI:10.1128/JVI.01455-15
Infusini G, Smith JM, Yuan H, Pizzolla A, Ng WC, Londrigan SL, Haque A, Reading PC, Villadangos JA and Wakim LM Respiratory DC Use IFITM3 to Avoid Direct Viral Infection and Safeguard Virus-Specific CD8+ T Cell Priming 2015 PLoS One 10(11): e0143539. 
PubMed link
DOI:10.1371/journal.pone.0143539
Londrigan SL, Tate MD, Job ER, Moffat JM, Wakim LM, Gonelli CA, Purcell DF, Brooks AG, Villadangos JA, Reading PC and Mintern JD Endogenous murine BST-2/Tetherin is not a major restriction factor of influenza A virus infection 2015 PLoS One 10(11): e0142925. 
PubMed link
DOI:10.1371/journal.pone.0142925
Little K, Leang SK, Butler J, Baas C, Harrower B, Mosse J, Barr IG and Hurt AC Zanamivir-resistant influenza viruses with Q136K or Q136R neuraminidase residue mutations can arise during MDCK cell culture creating challenges for antiviral susceptibility monitoring 2015 Euro Surveill 20(45). 
PubMed link
DOI:10.2807/1560-7917.ES.2015.20.45.30060
Grillo VL, Arzey KE, Hansbro PM, Hurt AC, Warner S, Bergfeld J, Burgess GW, Cookson B, Dickason CJ, Ferenczi M, Hollingsworth T, Hoque M, Jackson RB, Klaassen M, Kirkland PD, Kung NY, Lisovski S, O'Dea MA, O'Riley K, Roshier D, Skerratt LF, Tracey JP, Wang X, Woods R and Post L Avian influenza in Australia: a summary of 5 years of wild bird surveillance 2015 Aust Vet J 93(11): 387-393. 
PubMed link
DOI:10.1111/avj.12379
Chua BY, Wong CY, Mifsud EJ, Edenborough KM, Sekiya T, Tan AC, Mercuri F, Rockman S, Chen W, Turner SJ, Doherty PC, Kelso A, Brown LE and Jackson DC Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-yerm adaptive immunity 2015 MBio 6(6): e01024-01015. 
PubMed link
DOI:10.1128/mBio.01024-15
Ng WC, Londrigan SL, Nasr N, Cunningham AL, Turville S, Brooks AG and Reading PC The C-type lectin langerin functions as a receptor for attachment and infectious entry of influenza A virus 2015 J Virol 90(1): 206-221. 
PubMed link
DOI:10.1128/JVI.01447-15
Petrie SM, Butler J, Barr IG, McVernon J, Hurt AC and McCaw JMQuantifying relative within-host replication fitness in influenza virus competition experiments2015J Theor Biol 382: 259-271. 
PubMed link
DOI:10.1016/j.jtbi.2015.07.003
Sullivan SG and Cowling BJ "Crude Vaccine Effectiveness" is a misleading term in test-negative studies of influenza vaccine effectiveness 2015 Epidemiology 26(5): e60. 
PubMed link
DOI:10.1097/EDE.0000000000000343
Ampofo WK, Azziz-Baumgartner E, Bashir U, Cox NJ, Fasce R, Giovanni M, Grohmann G, Huang S, Katz J, Mironenko A, Mokhtari-Azad T, Sasono PM, Rahman M, Sawanpanyalert P, Siqueira M, Waddell AL, Waiboci L, Wood J, Zhang W, Ziegler T and WHO Working Group Strengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014 2015 Vaccine 33(36): 4368-4382. 
PubMed link
DOI:10.1016/j.vaccine.2015.06.090
Cao P, Yan AW, Heffernan JM, Petrie S, Moss RG, Carolan LA, Guarnaccia TA, Kelso A, Barr IG, McVernon J, Laurie KL and McCaw JM Innate immunity and the inter-exposure interval determine the dynamics of secondary influenza virus infection and explain observed viral hierarchies 2015 PLoS Comput Biol 11(8): e1004334. 
PubMed link
DOI:10.1371/journal.pcbi.1004334
Wang J, Moore NE, Deng YM, Eccles DA and Hall RJ MinION nanopore sequencing of an influenza genome 2015 Front Microbiol 6: 766. 

PubMed link
DOI:10.3389/fmicb.2015.00766
Su YC, Bahl J, Joseph U, Butt KM, Peck HA, Koay ES, Oon LL, Barr IG, Vijaykrishna D and Smith GJ Phylodynamics of H1N1/2009 influenza reveals the transition from host adaptation to immune-driven selection 2015 Nat Commun 6: 7952. 
PubMed link
DOI:10.1038/ncomms8952
Laurie KL, Engelhardt OG, Wood J, Heath A, Katz JM, Peiris M, Hoschler K, Hungnes O, Zhang W and Van Kerkhove MD International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 2015 Clin Vaccine Immunol 22(8): 957-964. 
PubMed link
DOI:10.1128/CVI.00278-15
Panozzo J, Oh DY, Margo K, Morton DA, Piedrafita D, Mosse J and Hurt AC Evaluation of a dry powder delivery system for laninamivir in a ferret model of influenza infection 2015 Antiviral Res 120: 66-71. 
PubMed link
DOI:10.1016/j.antiviral.2015.05.007
Bedford T, Riley S, Barr IG, Broor S, Chadha M, Cox NJ, Daniels RS, Gunasekaran CP, Hurt AC, Kelso A, Klimov A, Lewis NS, Li X, McCauley JW, Odagiri T, Potdar V, Rambaut A, Shu Y, Skepner E, Smith DJ, Suchard MA, Tashiro M, Wang D, Xu X, Lemey P and Russell CA Global circulation patterns of seasonal influenza viruses vary with antigenic drift 2015 Nature 523(7559): 217-220. 
PubMed link
DOI:10.1038/nature14460
Deng YM, Spirason N, Iannello P, Jelley L, Lau H and Barr IG A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses 2015 J Clin Virol 68: 43-48. 
PubMed link
DOI:10.1016/j.jcv.2015.04.019
Farrukee R, Leang SK, Butler J, Lee RT, Maurer-Stroh S, Tilmanis D, Sullivan S, Mosse J, Barr IG and Hurt AC Influenza viruses with B/Yamagata- and B/Victoria-like neuraminidases are differentially affected by mutations that alter antiviral susceptibility 2015 J Antimicrob Chemother 70(7): 2004-2012. 
PubMed link
DOI:10.1093/jac/dkv065
Patterson Ross Z, Komadina N, Deng YM, Spirason N, Kelly HA, Sullivan SG, Barr IG and Holmes EC Inter-seasonal influenza is characterized by extended virus transmission and persistence 2015 PLoS Pathog 11(6): e1004991. 
PubMed link
DOI:10.1371/journal.ppat.1004991
Bird NL, Olson MR, Hurt AC, Oshansky CM, Oh DY, Reading PC, Chua BY, Sun Y, Tang L, Handel A, Jackson DC, Turner SJ, Thomas PG and Kedzierska K Oseltamivir prophylaxis reduces inflammation and facilitates establishment of cross-strain protective T cell memory to influenza viruses 2015 PLoS One 10(6): e0129768. 
PubMed link
DOI:10.1371/journal.pone.0129768
Jiang L, Lee VJ, Lim WY, Chen MI, Chen Y, Tan L, Lin RT, Leo YS, Barr I and Cook AR Performance of case definitions for influenza surveillance 2015 Euro Surveill 20(22). 
PubMed link
Barr IG and Kelly HA Oseltamivir reduces clinical illness in households in Bangladesh 2015 Lancet Infect Dis 15(6): 617-619. 
PubMed link
DOI:10.1016/S1473-3099(15)70084-8
Hsu AC, Starkey MR, Hanish I, Parsons K, Haw TJ, Howland LJ, Barr I, Mahony JB, Foster PS, Knight DA, Wark PA and Hansbro PM Targeting PI3K-p110alpha Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease 2015 Am J Respir Crit Care Med 191(9): 1012-1023. 
PubMed link
DOI:10.1164/rccm.201501-0188OC
Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC and Tashiro M Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014 2015 Antiviral Res 117: 27-38. 
PubMed link
DOI:10.1016/j.antiviral.2015.02.003
Mohr PG, Deng YM and McKimm-Breschkin JL The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding 2015 Virol J 12: 67. 
PubMed link
DOI:10.1186/s12985-015-0295-3
Oh DY, Barr IG and Hurt AC A novel video tracking method to evaluate the effect of influenza infection and antiviral treatment on ferret activity 2015 PLoS One 10(3): e0118780. 
PubMed link
DOI:10.1371/journal.pone.0118780
Proudfoot O, Esparon S, Tang CK, Laurie K, Barr I and Pietersz G Mannan adjuvants intranasally administered inactivated influenza virus in mice rendering low doses inductive of strong serum IgG and IgA in the lung 2015 BMC Infect Dis 15(1): 101. 
PubMed link
DOI:10.1186/s12879-015-0838-7
Foo SS, Chen W, Taylor A, Sheng KC, Yu X, Teng TS, Reading PC, Blanchard H, Garlanda C, Mantovani A, Ng LF, Herrero LJ and Mahalingam S Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation 2015 PLoS Pathog 11(2): e1004649. 
PubMed link
DOI:10.1371/journal.ppat.1004649
Fox A, Mai le Q, Thanh le T, Wolbers M, Le Khanh Hang N, Thai PQ, Thi Thu Yen N, Minh Hoa le N, Bryant JE, Duong TN, Thoang DD, Barr IG, Wertheim H, Farrar J, Hien NT and Horby P Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection 2015 J Infect 70(2): 187-196. 
PubMed link
DOI:10.1016/j.jinf.2014.09.003
Lee HK, Tang JW, Loh TP, Hurt AC, Oon LL and Koay ES Molecular surveillance of antiviral drug resistance of influenza A/H3N2 virus in Singapore, 2009-2013 2015 PLoS One 10(1): e0117822. 
PubMed link
DOI:10.1371/journal.pone.0117822
Vijaykrishna D, Holmes EC, Joseph U, Fourment M, Su YC, Halpin R, Lee RT, Deng YM, Gunalan V, Lin X, Stockwell TB, Fedorova NB, Zhou B, Spirason N, Kuhnert D, Boskova V, Stadler T, Costa AM, Dwyer DE, Huang QS, Jennings LC, Rawlinson W, Sullivan SG, Hurt AC, Maurer-Stroh S, Wentworth DE, Smith GJ and Barr I The contrasting phylodynamics of human influenza B viruses 2015 Elife 4. 
PubMed link
DOI:10.7554/eLife.05055
Carville KS, Grant KA, Sullivan SG, Fielding JE, Lane CR, Franklin L, Druce J and Kelly HA Understanding influenza vaccine protection in the community: An assessment of the 2013 influenza season in Victoria, Australia 2015 Vaccine 33(2): 341-345. 
PubMed link
DOI:10.1016/j.vaccine.2014.11.019
Hurt AC, Hui DS, Hay A and Hayden FG Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management 2015 Influenza Other Respir Viruses 9(1): 20-31. 
PubMed link
DOI:10.1111/irv.12293

Top of Page